Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Sales | 3,008 | 4,473 | 1,917 | 1,731 | 1,823 |
| Cost of Goods | 155 | 135 | 158 | 148 | 206 |
| Gross Profit | 2,853 | 4,338 | 1,759 | 1,583 | 1,617 |
| Operating Expenses | 16,949 | 18,384 | 15,796 | 13,211 | 12,390 |
| Operating Income | -13,941 | -13,911 | -13,879 | -11,480 | -10,567 |
| Other Income | 698 | 1,168 | 1,089 | 1,238 | 1,364 |
| Pre-tax Income | -13,243 | -12,743 | -12,790 | -10,242 | -9,203 |
| Net Income Continuous | -13,243 | -12,743 | -12,790 | -10,242 | -9,203 |
| Net Income | $-13,243 | $-12,743 | $-12,790 | $-10,242 | $-9,203 |
| EPS Basic Total Ops | -517.84 | -489.85 | -531.84 | -405.88 | -363.89 |
| EPS Basic Continuous Ops | -511.20 | -492.34 | -510.48 | -410.61 | -369.22 |
| EPS Diluted Total Ops | -517.84 | -489.85 | -531.84 | -405.88 | -363.89 |
| EPS Diluted Continuous Ops | -511.20 | -492.34 | -510.48 | -410.61 | -369.22 |
| EBITDA(a) | $-16,306 | $-16,342 | $-15,245 | $-12,650 | $-11,744 |